Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation
- 19 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (5) , 2762-2776
Abstract
OCT1 is the most highly expressed cation transporter in the liver and affects pharmacokinetics and pharmacodynamics. Newly marketed drugs have previously been screened as potential OCT1 substrates and verified by virtual docking. Here, we used machine learning with transport experiment data to predict OCT1 substrates based on classic molecular descriptors, pharmacophore features, and extended-connectivity fingerprints and confirmed them by in vitro uptake experiments. We virtually screened a database of more than 1000 substances. Nineteen predicted substances were chosen for in vitro testing. Sixteen of the 19 newly tested substances (85%) were confirmed as, mostly strong, substrates, including edrophonium, fenpiverinium, ritodrine, and ractopamine. Even without a crystal structure of OCT1, machine learning algorithms predict substrates accurately and may contribute not only to a more focused screening in drug development but also to a better molecular understanding of OCT1 in general.Keywords
This publication has 59 references indexed in Scilit:
- Organic Cation Transporters in Health and DiseasePharmacological Reviews, 2020
- Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine contentPLOS Biology, 2018
- Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidinePLOS ONE, 2017
- Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 DeficiencyClinical Pharmacology & Therapeutics, 2017
- OCT1 mediates hepatic uptake of sumatriptan and loss‐of‐functionOCT1polymorphisms affect sumatriptan pharmacokineticsClinical Pharmacology & Therapeutics, 2016
- ABCC3 and OCT1 Genotypes Influence Pharmacokinetics of Morphine in ChildrenPharmacogenomics, 2014
- Human metabolic individuality in biomedical and pharmaceutical researchNature, 2011
- Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†Hepatology, 2009
- Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell LinesDrug Metabolism and Disposition, 2007
- Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin PharmacokineticsClinical Pharmacology & Therapeutics, 2007